| Indicators | Browse All

The Oncology Institute, Inc. (TOIIW)

Cerritos, United States |
USD

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 6:45 a.m. UTC

The security is effectively dead money with no path to recovery. Fundamentally, the company is hemorrhaging cash with negative operating margins and a massive debt load that dwarfs its cash reserves, creating an imminent liquidity crisis. The balance sheet is broken, with negative book value and no free cash flow to service obligations or fund operations. While revenue growth appears positive on paper, it is irrelevant given the operational losses and insolvency risks. There is no dividend to speak of, offering zero income to investors. Technically, the stock is trapped in a micro-cap range with negligible volume, showing no signs of life or institutional interest. The lack of price history prevents any assessment of long-term trends, but the current fundamental reality is dire. This is a clear sell/avoid scenario for any rational capital allocator.

None
Attribute Value
Revenue per Share 5.537
Beta 0.42
Profit Margins -7.97%
Website https://theoncologyinstitute.com

Info Dump

Attribute Value
Address1 18,000 Studebaker Road
Address2 Suite 800
Ask 0.0
Ask Size 0
Beta 0.422
Bid 0.0
Bid Size 0
Book Value -0.163
City Cerritos
Compensation As Of Epoch Date 1,767,139,200
Country United States
Currency USD
Current Price 0.049
Current Ratio 1.473
Day High 0.05
Day Low 0.049
Ebitda -25,909,000
Ebitda Margins -0.047470003
Exchange NCM
Exchange Timezone Name UTC
Fifty Two Week High 0.05
Fifty Two Week Low 0.049
Financial Currency USD
First Trade Date Epoch Utc 1,784,295,000
Float Shares 86,668,206
Free Cashflow -15,312,625
Full Time Employees 641
Fullday Price 0.049
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.15117
Gross Profits 82,501,000
Industry
Industry Key
Long Business Summary The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Long Name The Oncology Institute, Inc.
Max Age 86,400
Message Board Id finmb_661363343
Net Income To Common -36,324,000
Open 0.1817
Operating Cashflow -21,814,000
Operating Margins -0.04417
Phone 562 735 3226
Previous Close 0.0
Price Hint 4
Profit Margins -0.079730004
Quick Ratio 1.131
Quote Type EQUITY
Recommendation Key none
Regular Market Day High 0.05
Regular Market Day Low 0.049
Regular Market Open 0.1817
Regular Market Previous Close 0.0
Regular Market Volume 5
Return On Assets -0.122980006
Revenue Growth 0.412
Revenue Per Share 5.537
Sand P52 Week Change 0.20504117
Sector
Sector Key
Short Name The Oncology Institute, Inc.
State CA
Symbol TOIIW
Time Zone Full Name America/New_York
Time Zone Short Name EDT
Total Cash 30,280,000
Total Cash Per Share 0.303
Total Debt 104,913,000
Total Revenue 545,763,968
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield NaN
Trailing Eps -602.087
Trailing Peg Ratio None
Underlying Symbol TOIIW
Uuid 1a8399c3-b592-3e1c-8fbc-7f1ad88effd8
Volume 5
Website https://theoncologyinstitute.com
Zip 90,703